|
Sign In to gain access to subscriptions and/or personal tools.
|
Naturally Occurring and Experimental Diabetes in Cynomolgus Monkeys: A Comparison of Carbohydrate and Lipid Metabolism and Islet Pathology
Janice D. Wagner
Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1040
J. Mark Cline
Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1040
Melanie K. Shadoan
Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1040
Bill C. Bullock
Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1040
Samuel E. Rankin
Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1040
William T. Cefalu
Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont 05405
Diabetes is a major health problem of increasing incidence in the United States. Diabetes research has been limited by lack of availability of good animal models, particularly for the study of comorbidities associated with diabetes. We investigated the use of cynomolgus monkeys as an animal model of both type 1 and type 2 diabetes and compared these naturally occurring diseases with streptozotocin-induced diabetes. Both type 1 diabetics and streptozotocin-induced diabetics present with sudden onset of hyperglycemia and are ketosis prone without exogenous insulin. Type 2 diabetics can have a very long period of moderate hyperglycemia and hypertriglyceridemia and only require exogenous insulin therapy if pancreatic islet reserves are depleted. Type 2 diabetes is preceded by a relatively long period of insulin resistance that is associated with obesity and dyslipidemia. As insulin resistance progresses, islet size and insulin content increases initially. However, with sustained periods of insulin resistance, islet amyloid polypeptide (IAPP) is deposited in islets and can replace normal islet architecture, resulting in an insulin-deficient state. Appearance of IAPP also occurs in human type 2 diabetics but not in conventional rodent models. Unlike type 2 diabetes, neither type 1 nor streptozotocin-induced diabetes is associated with IAPP. Rather, islets can appear normal histologically, but have decreased insulin secretion and immunostaining. Further, the amount of insulin present in the islet is correlated with plasma insulin levels following glucose challenge. Studies are ongoing to determine the pathogenic changes associated with the progression of diabetes and to find novel drug treatments for diabetics.
Key Words: Insulin • glucagon • pancreatic islets • amyloid • endocrine disease • monkeys
References
- Applebaum-Bowden D., Haffner SM, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Hazzard WR (1985). Postheparin plasma triglyceride lipases: Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol. Arteriosclerosis 5: 273—282.[Abstract/Free Full Text]
- Bagdade JD, Wagner JD, Rudel LL, Clarkson TB (1995). Accelerated cholesteryl ester transfer and altered lipoprotein composition in diabetic cynomolgus monkeys. J Lipid Res 36: 759—766.[Abstract]
- Bierman EL (1992). Atherogenesis in diabetes. Arterioscler Thromb 12: 647—656.[Free Full Text]
- Cefalu WT, Wagner JD, Bell-Farrow AD (1993). Role of glycated proteins in detecting and monitoring diabetes in cynomolgus monkeys. Am Assoc Lab Anim Sci 43: 73—77.[Web of Science][Medline]
[Order article via Infotrieve]
- Diabetes Research Working Group (1999). Summary of the report and recommendations of the Congressionally-established Diabetes Research Working Group. In: Conquering Diabetes: A Strategic Plan for the 21st Century. National Institutes of Health Publication No 99-4398, National Diabetes Information Clearinghouse, Bethesda, MD.
- Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1999). Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 22: 5—19.
- Hoppener JWM, Ahren B., Lips CJM (2000). Islet amyloid and type 2 diabetes mellitus. N Engl J Med 343: 411—419.[Free Full Text]
- Kahn SE, Andrikopoulos S., Verchere CB (1999). Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 48: 241—253.[Abstract]
- Litwak KN, Cefalu WT, Wagner JD (1998). Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys. Metabolism 47: 1—8.[Web of Science][Medline]
[Order article via Infotrieve]
- Litwak KN, Cefalu WT, Wagner JD (1998). Streptozotocin-induced diabetes mellitus in cynomolgus monkeys: Changes in carbohydrate metabolism, skin glycation, and pancreatic islets. Lab Anim Sci 48: 172—178.[Web of Science][Medline]
[Order article via Infotrieve]
- Nordestgaard BG, Stender S., Kjos SL (1988). Reduced atherogenesis in cholesterol-fed diabetic rabbits: Giant lipoproteins do not enter the arterial wall. Arteriosclerosis 8: 421—428.[Abstract/Free Full Text]
- O'Brien TD, Wagner JD, Litwak KN, Carlson CS, Cefalu WT, Jordan K., Johnson KH, Butler PC (1996). Islet amyloid and islet amyloid polypeptide in cynomolgus macaques (Macacafascicularis): An animal model of human non-insulin dependent diabetes mellitus. Vet Pathol 33: 479 — 485.[Abstract]
- Reaven PD, Merat S., Casanada F., Sutphin M., Palinski W. (1997). Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 17: 2250—2256.[Abstract/Free Full Text]
- Sheehan DC, Hrapchak BB (1980). Carbohydrates. In: Theory and Practice of Histotechnology, Sheehan DC, Hrapchak BB (eds). C.V. Mosby Co, St. Louis, pp 177—178.
- Unger RH, Foster DW (1998). Diabetes mellitus. In: Williams Textbook of Endocrinology, Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds). W.B. Saunders Co, Philadelphia, pp 973—1059.
- Wagner JD, Bagdade JD, Litwak KN, Zhang L., Bell-Farrow AD, Wang ZQ, Cefalu WT (1996). Increased glycation of plasma lipoproteins in diabetic cynomolgus monkeys. Lab Anim Sci 46: 31— 35.
- Wagner JD, Carlson CS, O'Brien TD, Anthony MS, Bullock BC, Cefalu WT (1996). Diabetes mellitus and islet amyloidosis in cynomolgus monkey. Lab Anim Sci 46: 36—41.[Web of Science][Medline]
[Order article via Infotrieve]
- Wagner JD, Jayo MJ, Bullock BC, Washburn SA (1992). Gestational diabetes mellitus in a cynomolgus monkey with group A streptococcal metritis and hemolytic uremic syndrome. J Med Primatol 21: 371—374.[Web of Science][Medline]
[Order article via Infotrieve]
- Weir GC, Leahy JL (1994). Pathogenesis of non-insulin-dependent (type II) diabetes mellitus. In: Joslin's Diabetes Mellitus, Kahn CR, Weir GC (eds). Lea & Febiger, Malvern, Pennsylvania, pp 240 — 264.
- Weyer C., Bogardus C., Mott DM, Pratley RE (1999). The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104: 787—794.[Web of Science][Medline]
[Order article via Infotrieve]
Toxicologic Pathology, Vol. 29, No. 1,
142-148 (2001)
DOI: 10.1080/019262301301418955
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
L. J. Lowenstine
A Primer of Primate Pathology: Lesions and Nonlesions
Toxicol Pathol,
January 1, 2003;
31(1_suppl):
92 - 102.
[Abstract]
[PDF]
|
|
|
|
|
